MD. Sinan Çağlayan

Education2006 Gulhane Military Medical Academy, Haydarpaşa Training Hospital of Endocrinology and Metabolism Service, Medical Subspecialty1999 Gulhane Military Medical Academy, Gate Department of Internal Medicine, Specialist1989 Ankara University Medical SchoolProfessional Experience2015 KadıköyŞifa Ataşehir Hospital2011 - 2012 GATA Haydarpasa Training Hospital of Endocrinology and Metabolism , Associate Professor2007 - 2011 GATA Haydarpasa Training Hospital of Endocrinology and Metabolism , Asst. Prof2003 - 2006 GATA Haydarpasa Training Hospital of Endocrinology and Metabolism , Specialist2000 - 2002 UCLA David Geffen School of Medicine, Neuropsychiatric Institute, Los Angeles, CA/USA, (fellow)1995 - 1999 Gata Military Faculty of Medicine, Department of Internal Medicine, specialists in medicineMemberships2009 European Association for the Study of Diabetes (EASD)2006 Istanbul University Research Institute of Experimental Medicine, Metabolism and Diabetes Research Unit (MEDAB) Scientific Committee Member2003 Turkey Endocrinology and Metabolism SocietyPublicationsA1. Ozata M., C. Tayfun, K. Kurtaran, I. Yetkin, Z. Beyhan, A. Corakcı, S. Caglayan, A. Alemdaroglu, M. A. Gundogan A, “Magnetic Resonance Imaging of Posterior Pituitary for Evaluation of The Neurohypophysial Diabetes Insipitus”, Eur. Radiol., (7), 1098-1102, (1997).A2. Ozata M., G. Ozisik, S. Caglayan, Z. Yesilova, N. Bingol, M. Saglam, M. Turan, Z. Beyhan, “Effects of Gonadotropin and Testosterone Treatments on Plasma Leptin Levels in Male Patients with Idıopathic Hypogonadotropic Hypogonadism and Klinefelter’s Syndrome”, Horm. Metab. Res., (30), 266-271, (1998).A3. Bulucu F., S. Erikci, A. Vural, S. Caglayan, Letter to Editor, “Polysthemia Vera Concurrent with Chronic Renal Failure”, Nephron, (80), 486-7, (1998).A4. Ozata M., Z. Odabasi, S. Caglayan, Z. Beyhan, O. Vural, I. C. Ozdemir, “Event-related Brain Potentials in Male Hypogonadism”, J Endocrinol Invest., (22), 508-513, (1999).A5. Caglayan S., M. Ozata, G. Ozisik, M. Turan, E. Bolu, C. Oktenli, N. Arslan, K. Erbil, D. Gul, I. C. Ozdemir, “Plasma Melatonin Concentration Before and During Testosterone Replacement in Klinefelter’s Syndrome: Relation with Hepatic Indolamine Metabolism and Sympathoadrenal Activity”, J. Clin. Endocrinol. Metab., February 1, 86(2), 738-743, (2001).A6. Ozisik G., H. Mergen, M. Ozata, C. Uyanik, S. Caglayan, M. Turan, E. Bolu, S. Ilgin, R. Oner, I. C. Ozdemir, C. Oner, “Vitamin D-receptor Gene Polymorphism and Vertebral Bone Density in Men with Idiopathic Hypogonadotophic Hypogonadism”, Med. Sci. Monit., 7(2), 233-7, (2001).A7. Mantzoros C. S., M. Ozata, A. B. Negrao, M. Ziotopoulou, S. Caglayan, M. Suchard, R. J. Cogswell, P. Negro, R. M. Elashoff, V. Liberty, M-L. Wong, J. D. Veldhuis, I. C. Ozdemir, P. W. Gold, J. S. Flier, J. Licinio, “Synchronicity of frequently sampled TSH and leptin concentrations in healthy adults and leptin deficient subjects: evidence for possible partial TSH regulation by leptin in humans”, J. Clin. Endocrinol. Metab., July, 86(7), 3284-91, (2001).A8. Licinio, J., S. Caglayan, M. Ozata, B. O. Yildiz, P. B. de Miranda, F. O’Kirwan, R. Whitby, L. Liang, P. Cohen, S. Bhasin, R. M. Krauss, J. D. Veldhuis, A. J. Wagner, A. DePaoli, S. M. McCann, M-L. Wong, “Phenotypic effects of leptin replacement on morbid obesity, diabetes mellitus, hypogonadism, and behavior in leptin-deficient adults”, PNAS, March 30, 101(13), 4531-36, (2004).A9. Matochik, J.A., E. D. London, B. O. Yildiz, M. Ozata, S. Caglayan, A. M. DePaoli, M-L. Wong, J. Licinio, “Effect of leptin replacement on brain structure in genetically leptin-deficient adults”, J. Clin. Endocrinol. Metab., May, 90(5), 2851-4, (2005).A10. Williamson, D. A., E. Ravussin, M-L. Wong, A. Wagner, A. DiPaoli, S. Caglayan, M. Ozata, C. Martin, H. Walden, C. Arnett, J. Licinio. “Microanalysis of eating behavior of three leptin deficient adults treated with leptin therapy”, Appetite, 45, 75–80, (2005).A11. Caglayan, S., M. Ozata, “Congenital Leptin Deficiency”, Obesity and Metabolism, 4(1), 42-58, (2008).A12. Erikci, A.A., B. Karagoz, A. Ozturk, S. Caglayan, G. Ozisik, I. Kaygusuz, M. Ozata, “The effect of subclinical hypothyroidism on platelet parameters”, Hematology, 14(2), 115-117, (2009).A13. Caglayan, S., M. Urhan, O. Sildiroğlu, Y. Kurt, M. E. Onde, Y. Narin, “Management of thyroid cancer associated with elevated serum thyroglobulin and negative radioiodine scanning”, Turk. J. Med. Sci., 39(5), 693-699, (2009).A14. Aral C., M. Akkiprik, H. Kaya, Ç. Ataizi-Çelikel, S. Çağlayan, G. Özisik, H. Baloğlu, A. Özer, “Mitochondrial DNA common deletion is not associated with thyroid, breast and colorectal tumors in Turkish patients”, Genet Mol Biol., 33(1),1-4, (2010).A15. Galgani J. E., F. L. Greenway, S. Caglayan, Ma-Li Wong, J. Licinio, E. Ravussin, “Leptin Replacement Prevents Weight Loss-Induced Metabolic Adaptation in Congenital Leptin-Deficient Patient”, J. Clin. Endocrinol. Metab., February, 95, 851-855, (2010).A16. Akkiprik, M., F. Özdemir, S. Çağlayan, C. Aral, G. Özışık, Z. Atabey, M. Özata, A. Özer, “Association of ACP1 genotypes and clinical parameters in patients with metabolic syndrome”, Turk J Med Sci., 41(1), 1-9, (2011).A17. Aral, C., M. Akkiprik, S. Caglayan, Z. Atabey, G. Ozisik, N. Bekiroglu, A. Ozer, “Investigation of relationship of the mitochondrial DNA 16189 T>C polymorphism with metabolic syndrome and its associated clinical parameters in Turkish patients”, Hormones, 10(4), 298-303, (2011).B. Ulusal hakemli dergilerde yayımlanan makaleler:B1. Önde, M. E., Ö. Azal., S. Çağlayan, M. A. Gündoğan, “Atipik Aarskog Sendromu Olgusu”, GATA Bülteni,(38), 529-533, (1996). B2. Aral, C., S. Çağlayan, G. Özışık, Ş. Massoumilary, Ö. Sönmez, M. Akkiprik, H. Baloğlu, M. Özata, A. Özer, “The Association of P53 Codon 72 Polymorphism with Thyroid Cancer in Turkish Patients”, Marmara Medical Journal, 20(1), 1-5, (2007). B3. Özsarı, L., M. Alış, G. Özışık, S. Çağlayan, M. Emin Önde, “Endoskopik ultrasonografi ile saptanan bir insülinoma olgusu”, Gülhane Tıp Dergisi 53:281-283, (2011).B4. Sinan Çağlayan, “Diyabetik Dislipidemi” Türkiye Klinikleri/Endocrine Special Topics, 5 (1):38-46 (2012).